High moxifloxacin cross-resistance levels among “newly identified” ofloxacin-resistant multidrug-resistant tuberculosis patients from South India: A ticking bomb or a tricky challenge? | Zendy

Praveen Sanker | Zendy; Anjana Satheesan | Zendy; AnusreeP Ambika | Zendy; VishnuT Santhosh | Zendy; Ravikrishnan Balakrishnan | Zendy; SunilKumar Mrithunjayan | Zendy

Open Access

High moxifloxacin cross-resistance levels among “newly identified” ofloxacin-resistant multidrug-resistant tuberculosis patients from South India: A ticking bomb or a tricky challenge?

Author(s) -

Praveen Sanker,

Anjana Satheesan,

AnusreeP Ambika,

VishnuT Santhosh,

Ravikrishnan Balakrishnan,

SunilKumar Mrithunjayan

Publication year - 2017

Publication title -

biomedical and biotechnology research journal (bbrj)

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.214

H-Index - 5

eISSN - 2588-9842

pISSN - 2588-9834

DOI - 10.4103/bbrj.bbrj_7_17

Subject(s) - ofloxacin , moxifloxacin , medicine , gatifloxacin , tuberculosis , rifampicin , multiple drug resistance , drug resistance , cross resistance , bedaquiline , capreomycin , mycobacterium tuberculosis , antibiotics , pharmacology , microbiology and biotechnology , ciprofloxacin , virology , ethambutol , biology , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research